The Relative Cost-Effectiveness of Anticoagulants Obvious, Except for the Cost and the Effectiveness

被引：29

作者：

Avorn, Jerry ^{[1
,2
]}

机构：

[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA 02120 USA

[2] Harvard Univ, Sch Med, Boston, MA 02120 USA

来源：

CIRCULATION | 2011年 / 123卷 / 22期

关键词：

anticoagulants; cost-effectiveness; economics; warfarin; ATRIAL-FIBRILLATION; STROKE PREVENTION; WARFARIN; DABIGATRAN; EVENTS;

D O I：

10.1161/CIRCULATIONAHA.111.030148

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2519 / 2521

页数：3

共 16 条

[1] Safety assessment of new antithrombotic agents: Lessons from the EXTEND study on ximelagatran [J].

Agnelli, G. ;

Eriksson, E. L. ;

Cohen, A. T. ;

Bergqvist, D. ;

Dahl, O. E. ;

Lassen, M. R. ;

Mouret, P. ;

Rosencher, N. ;

Andersson, M. ;

Bylock, A. ;

Jensen, E. ;

Boberg, B. .

THROMBOSIS RESEARCH, 2009, 123 (03) :488-497

[2] Developing the Sentinel System - A National Resource for Evidence Development [J].

Behrman, Rachel E. ;

Benner, Joshua S. ;

Brown, Jeffrey S. ;

McClellan, Mark ;

Woodcock, Janet ;

Platt, Richard .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06) :498-499

[3] Use and effectiveness of warfarin in medicare beneficiaries with atrial fibrillation [J].

Birman-Deych, E ;

Radford, MJ ;

Nilasena, DS ;

Gage, BF .

STROKE, 2006, 37 (04) :1070-1074

[4] Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis [J].

Choudhry, NK ;

Anderson, GM ;

Laupacis, A ;

Ross-Degnan, D ;

Normand, SLT ;

Soumerai, SB .

BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7534) :141-143

[5] Newly Identified Events in the RE-LY Trial [J].

Connolly, Stuart J. ;

Ezekowitz, Michael D. ;

Yusuf, Salim ;

Reilly, Paul A. ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (19) :1875-1876

[6] Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].

Connolly, Stuart J. ;

Ezekowitz, Michael D. ;

Yusuf, Salim ;

Eikelboom, John ;

Oldgren, Jonas ;

Parekh, Amit ;

Pogue, Janice ;

Reilly, Paul A. ;

Themeles, Ellison ;

Varrone, Jeanne ;

Wang, Susan ;

Alings, Marco ;

Xavier, Denis ;

Zhu, Jun ;

Diaz, Rafael ;

Lewis, Basil S. ;

Darius, Harald ;

Diener, Hans-Christoph ;

Joyner, Campbell D. ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151

[7]

Freeman JV, 2011, ANN INTERN MED, V154, P570, DOI 10.7326/0003-4819-154-8-201104190-00014

[8] Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation [J].

Freeman, James V. ;

Zhu, Ruo P. ;

Owens, Douglas K. ;

Garber, Alan M. ;

Hutton, David W. ;

Go, Alan S. ;

Wang, Paul J. ;

Turakhia, Mintu P. .

ANNALS OF INTERNAL MEDICINE, 2011, 154 (01) :1-U129

[9] Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation [J].

Hart, Robert G. ;

Pearce, Lesly A. ;

Aguilar, Maria I. .

ANNALS OF INTERNAL MEDICINE, 2007, 146 (12) :857-867

[10] Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: Results of a survey of long-term care practitioners [J].

Monette, J ;

Gurwitz, JH ;

Rochon, PA ;

Avorn, J .

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (09) :1060-1065

← 1 2 →